Z. Hamersˇak et al. / Tetrahedron: Asymmetry 18 (2007) 635–644
643
added and stirred for 5 h at 75 ꢁC. Upon cooling to rt,
4.12. (ꢀ)-(1R,5S)-5-(9H-Fluoren-9-ylmethoxycarbonyl-
20 mL of H2O was added, and most of the solvent evapo-
rated. EtOAc extraction afforded an oily product, which
was recrystallized from EtOH/hexane to obtain 450 mg
(45%) of pure 13. Mp 133–135 ꢁC. 1H NMR (CDCl3):
d = 1.75 (s, 3H), 2.62 (dd, J = 16.5 Hz, 7 Hz, 1H), 2.72
(dd, J = 16.5 Hz, 8 Hz, 1H), 3.60 (dt, J = 9 Hz, 7 Hz,
1H), 4.00 (dq, J = 7 Hz, 1.5 Hz, 1H), 5.36 (s, 1H), 11.8
(br s, 2H). 13C NMR (CDCl3): 16.19, 39.89, 44.79, 53.56,
120.73, 141.99, 179.71, 180.80. IR (KBr): 3020, 2921,
1708, 1444, 1427, 1291, 1271, 1226, 942 cmꢀ1. Anal. Calcd
for C8H10O4 (170.16): C, 56.47; H, 5.92; Found: C, 56.78;
H, 5.70.
amino)-3-methyl-cyclopent-2-enecarboxylic acid 17
The first mother liquor obtained after the crystallization of
16 was evaporated, containing 1.85 g (5 mmol) of 16/17
(40/60 ratio). The residue was dissolved in 100 mL
CH2Cl2/hexane (3:7) and treated with dicyclohexylamine
(0.60 mL, 3.6 mmol). The precipitated salt was collected
on a filter, suspended in CH2Cl2 and the free acid liberated
with dil HCl. This procedure was repeated with 1 equiv of
dicyclohexylamine calculated on the quantity of 17 in the
mixture to obtain 0.46 g (5%) of 17, which was 97% pure.
25
Mp 61–63 ꢁC; ½aꢁD ¼ ꢀ91 (c 1, CH2Cl2). 1H NMR
(DMSO-d6): d = 1.73 (s, 3H), 2.41 (d, J = 7 Hz, 2H), 3.52
(d, J = 7 Hz, 1H), 4.12–4.48 (m, 4H), 5.21 (s, 1H), 7.28–
7.92 (m, 8H), 12.0 (br s, 1H). 13C NMR (DMSO-d6):
d = 17.20, 41.71, 47.14, 53.48, 54.36, 66.08, 120.52,
122.62, 125.75, 126.69, 127.54, 127.58, 128.08, 141.11,
141.15, 142.58, 144.20, 144.45, 156.14, 173.76. IR (KBr):
3408, 3313, 3063, 2935, 1715, 1512, 1450, 1344, 1230,
741 cmꢀ1. Anal. Calcd for C22H21NO4 (363.41): C, 72.71;
H, 5.82; N, 3.85. Found: C, 72.91; H, 5.52; N, 3.48.
4.10. ( )-cis-4-Methyl-cyclopent-3-ene-1,2-dicarboxylic acid
14
Anhydride 7 (300 mg, 2 mmol) was suspended in H2O
(20 mL) and stirred at 60 ꢁC for 1 h. The clear solution
was extracted with EtOAc to give 330 mg (97%) of pure
1
product. Mp 140–142 ꢁC. H NMR (CDCl3): d = 1.79 (s,
3H), 2.48 (dd, J = 16 Hz, 9 Hz, 1H), 2.93 (dd, J = 16 Hz,
9 Hz, 1H), 3.46 (psq, J = 9 Hz, 1H), 3.79 (d, J = 9 Hz,
1H), 5.35 (s, 1H), 11.6 (br s, 2H). 13C NMR (CDCl3):
d = 16.68, 37.98, 46.59, 53.12, 120.72, 145.07, 180.34,
180.56. IR (KBr): 3068, 2943, 2916, 1703, 1414, 1320,
1230, 813 cmꢀ1. Anal. Calcd for C8H10O4 (170.16): C,
56.47; H, 5.92; Found: C, 56.29; H, 5.66.
4.13. (+)-(1R,2S)-2-Amino-4-methyl-cyclopent-3-enecarb-
oxylic acid 3
A solution of 16 (3.3 g; 9.1 mmol) and morpholine (1.3 mL,
15 mmol) in 40 mL of abs. EtOH was refluxed for 3 h. The
solvent was evaporated; H2O (50 mL) was added and
washed with hexane (3 · 50 mL). The aqueous solution
was concentrated and passed through a short column of
Amberlite XAD-16. Evaporation of the eluate afforded
1.18 g of the crude product, which was recrystallized from
94% EtOH. Yield: 1.01 g (78%), HPLC purity 96% (Nucleo-
sil 100-5 RP18, 10% aqueous MeOH, 1% H3PO4, at 206 nm
4.11. (+)-(1R,2S)-2-(9H-Fluoren-9-ylmethoxycarbonyl-
amino)-4-methyl-cyclopent-3-enecarboxylic acid 16
A mixture of NaI (4.0 g 26 mmol) and TMSCl (4.5 mL,
35 mmol) in acetonitrile (200 mL) was stirred at rt for
30 min, (+)-1 (4.0 g, 28 mmol) was added and stirred over-
night at 75 ꢁC. Upon cooling to rt, 2 mL of H2O was added
and most of the solvent was evaporated in vacuum. The
residue was dissolved in H2O (100 mL) and washed with
CH2Cl2 (5 · 50 mL). To the aqueous solution, Na2CO3
(15 g) was added, followed by the portionwise addition of
a dioxane solution of 9-fluorenylmethyl-succinimidylcar-
bonate (9.5 g, 28 mmol) at 0 ꢁC. The reaction mixture
was stirred at rt for 6 h, after which H2O (100 mL) was
added and the aqueous solution was washed with diisoprop-
yl ether (3 · 50 mL). The aqueous solution was acidified to
pH 2 with dil HCl and extracted with diisopropyl ether.
The crude product contained a 65/35 ratio of 16/17 (deter-
mined by HPLC; Nucleosil 100-5, 3% EtOH in CH2Cl2),
and was recrystallized 3 times from EtOAc/hexane (1:2)
to afford 3.44 g (35%) of 16, 96% HPLC purity. Mp 144–
for 10 min; then gradient to 100% MeOH in 15 min at
25
254 nm). Mp 219–220 ꢁC (lit.14 221 ꢁC); ½aꢁD ¼ þ65 (c
0.8, H2O). 1H NMR (D2O): d = 1.72 (s, 3H), 2.51 (d,
J = 8 Hz, 2H), 3.25 (psq, J = 8 Hz, 1H), 4.15 (d,
J = 8 Hz, 1H), 5.38 (s, 1H). 13C NMR (D2O): d = 16.74,
39.32, 47.30, 57.54, 120.79, 151.41, 180.37. IR (KBr):
3429, 3138, 2911, 1649, 1625, 1563, 1398, 1282, 1175,
986, 798 cmꢀ1. Anal. Calcd for C7H11NO2 (141.17): C,
59.56; H, 7.85; N, 9.92. Found: C, 59.25; H, 8.05; N,
9.76.
4.14. (ꢀ)-(1R,5S)-5-Amino-3-methyl-cyclopent-2-enecarb-
oxylic acid 2
25
1
146 ꢁC; ½aꢁD ¼ þ78 (c 1, CH2Cl2). H NMR (DMSO-d6):
d = 1.73 (s, 3H), 2.17–2.26 (m, 1H), 2.70–2.79 (m, 1H),
3.22–3.36 (m, 2H), 4.10–4.25 (m, 2H), 4.80–4.95 (m, 1H),
5.21 (s, 1H), 7.28–7.92 (m, 8H), 12.05 (br s, 1H). 13C
NMR (DMSO-d6): d = 16.90, 37.85, 47.15, 47.67, 50.04,
66.06, 120.49, 120.51, 124.02, 125.84, 126.07, 127.53,
128.05, 128.07, 141.14, 143.14, 144.19, 144.55, 155.81,
173.68. IR (KBr): 3423, 3305, 3269, 2926, 1711, 1655,
1412, 1350, 1213, 1054, 740 cmꢀ1. Anal. Calcd for
C22H21NO4 (363.41): C, 72.71; H, 5.82; N, 3.85. Found:
C, 72.43; H, 5.55; N, 3.72.
The reaction was performed as described for 3. Starting
from 330 mg of 17 of 110 mg (86%) of 97% pure 2 was ob-
25
tained. Mp 189–190 ꢁC (lit.14 190 ꢁC); ½aꢁD ¼ ꢀ115 (c 1,
1
H2O). H NMR (D2O): d = 1.68 (d, J = 1 Hz, 3H), 2.61
(dd, J = 16 Hz, 4 Hz, 1H), 2.61 (dd, J = 16.5 Hz, 7.5 Hz,
1H), 3.51–3.58 (m, 1H), 3.88–3.96 (m, 1H), 5.37 (d,
J = 1.5 Hz, 1H). 13C NMR (D2O): d = 16.50, 40.09,
52.37, 52.45, 123.66, 141.12, 179.69. IR (KBr): 3438,
3052, 2946, 2183, 1654, 1552, 1506, 1393, 1176, 834 cmꢀ1
.
Anal. Calcd for C7H11NO2 (141.17): C, 59.56; H, 7.85;
N, 9.92. Found: C, 59.35; H, 7.98; N, 9.73.